Treatment with Lomecel-B in early Alzheimer's patients led to improvements in cognitive tests relative to a placebo in a clinical trial.| Alzheimer's News Today
The FDA granted regenerative medicine advanced therapy (RMAT) status to experimental cell therapy Lomecel-B for mild Alzheimer’s disease.| Alzheimer's News Today